<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02431039</url>
  </required_header>
  <id_info>
    <org_study_id>D-1503-016-653</org_study_id>
    <nct_id>NCT02431039</nct_id>
  </id_info>
  <brief_title>Comparison Between NEOSORB Plus and NEOSORB</brief_title>
  <official_title>Comparison of Intraoperative Handling and Wound Healing Between NEOSORB Plus Antibacterial Suture With NEOSORB Suture: Prospective, Single-blind, Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Seoul National University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Medical Research Collaborating Center, Seoul, Korea</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Korea Health Industry Development Institute</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Samyang Biopharmaceuticals Corporation</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Seoul National University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study is to investigate whether NEOSORB Plus antibacterial suture (chlorhexidine
      diacetate coated PGLA910) is not inferior to NEOSORB suture (PGLA910) in the points of
      intraoperative handling.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      1. Enrollment

             1. Urologic surgery which needs fascia and subcutaneous tissue repairs

             2. Clean and clean-contaminated surgery

             3. Patients aged more than 18 years and under 80 years

        2. Randomization

             1. NEOSORB Plus (chlorhexidine diacetate coated PGLA910) or NEOSORB (PGLA910) suture

             2. Stratification by operative methods: Open surgery vs. laparoscopic or
                robot-assisted laparoscopic surgery

        3. Follow-up with 30 days

             1. Primary endpoint: intraoperative handling during operation

             2. Secondary endpoint: wound healing assessment on postoperative 1st (+1) days and
                11th (± 4) days

             3. Safety evaluation: counting adverse events within postoperative 30 days
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>May 2015</start_date>
  <completion_date type="Actual">August 2015</completion_date>
  <primary_completion_date type="Actual">August 2015</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Overall handling</measure>
    <time_frame>During the operation</time_frame>
    <description>1 to 5 scale</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Ease of passage though tissue</measure>
    <time_frame>During the operation</time_frame>
    <description>1 to 5 scale</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>First-throw knot holding</measure>
    <time_frame>During the operation</time_frame>
    <description>1 to 5 scale</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Knot tie-down smoothness</measure>
    <time_frame>During the operation</time_frame>
    <description>1 to 5 scale</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Knot security</measure>
    <time_frame>During the operation</time_frame>
    <description>1 to 5 scale</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Surgical hand</measure>
    <time_frame>During the operation</time_frame>
    <description>1 to 5 scale</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Memory</measure>
    <time_frame>During the operation</time_frame>
    <description>1 to 5 scale</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Lack of fraying</measure>
    <time_frame>During the operation</time_frame>
    <description>1 to 5 scale</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Healing progress, apposition</measure>
    <time_frame>On postoperative 1st(+1) and 11th(±4) day</time_frame>
    <description>Complete vs. Incomplete</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Infection</measure>
    <time_frame>On postoperative 1st(+1) and 11th(±4) day</time_frame>
    <description>No vs. YES</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Seroma requiring drainage</measure>
    <time_frame>On postoperative 1st(+1) and 11th(±4) day</time_frame>
    <description>No vs. YES</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Suture sinus, culture-negative</measure>
    <time_frame>On postoperative 1st and 11(± 4)th day</time_frame>
    <description>No vs. YES</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Erythema</measure>
    <time_frame>On postoperative 1st(+1) and 11th(±4) day</time_frame>
    <description>0, + (closure line redness), ++(redness&lt;2mm), +++ (redness&gt;2mm)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Edema</measure>
    <time_frame>On postoperative 1st(+1) and 11th(±4) day</time_frame>
    <description>0, + (slight increase in firmness), ++(skin dimples with pressure), +++ (tense firmness)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain</measure>
    <time_frame>On postoperative 1st(+1) and 11th(±4) day</time_frame>
    <description>0, + (with pressure), ++(with touching), +++ (constant)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Skin temperative increase</measure>
    <time_frame>On postoperative 1st(+1) and 11th(±4) day</time_frame>
    <description>0, + (slight), ++(definite), +++ (hot, radiating)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>30 days cumulative skin infection rate</measure>
    <time_frame>Within postoperative 30 days</time_frame>
    <description>No vs. YES</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>30 days cumulative seroma requiring drainage rate</measure>
    <time_frame>Within postoperative 30 days</time_frame>
    <description>No vs. YES</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>30 days cumulative suture sinus (culture-negative) rate</measure>
    <time_frame>Within postoperative 30 days</time_frame>
    <description>No vs. YES</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Adverse events</measure>
    <time_frame>Within postoperative 30 days</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">100</enrollment>
  <condition>Skin Reaction to Suture Material</condition>
  <arm_group>
    <arm_group_label>NEOSORB PLUS</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Subjects who are treated by NEOSORB PLUS</description>
  </arm_group>
  <arm_group>
    <arm_group_label>NEOSORB</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Subjects who are treated by NEOSORB</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>NEOSORB PLUS</intervention_name>
    <description>Fascia and subcutaneous tissue repaired by antibacterial suture materials (Chlorhexidine diacetate coated PGLA910)</description>
    <arm_group_label>NEOSORB PLUS</arm_group_label>
    <other_name>Antibacterial suture material</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>NEOSORB</intervention_name>
    <description>Fascia and subcutaneous tissue repaired by non-antibacterial suture materials (PGLA910)</description>
    <arm_group_label>NEOSORB</arm_group_label>
    <other_name>Non-antibacterial suture material</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Urologic surgery which needs fascia and subcutaneous tissue repairs

          -  Clean and clean-contaminated surgery

        Exclusion Criteria:

          -  Contaminated surgery

          -  Wound requiring retention suture

          -  Suspicious malnutrition status

          -  Active infection status or AIDS

          -  Incision sites prone to expand, stretch, distend, or require support

          -  Allergy or hypersensitivity to chlorhexidine diacetate

          -  Significant active medical illness which in the opinion of the investigator would
             preclude protocol treatment
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Chang Wook Jeong, M.D.,Ph.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Seoul National University Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Seoul National University Hospital</name>
      <address>
        <city>Seoul</city>
        <zip>110-744</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>August 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 26, 2015</study_first_submitted>
  <study_first_submitted_qc>April 26, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 30, 2015</study_first_posted>
  <last_update_submitted>August 12, 2015</last_update_submitted>
  <last_update_submitted_qc>August 12, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 14, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Seoul National University Hospital</investigator_affiliation>
    <investigator_full_name>Chang Wook Jeong</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anti-Bacterial Agents</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

